Company intelligence / Profile preview

MEDExpansion

Ownership: Private
Development stage: Other

Overview

MEDExpansion is a Swiss-based consultancy with over 30 years of experience in the global medical ecosystem, specializing in helping companies elaborate clinical development plans and orchestrate activities with experts, particularly in oncology and orphan diseases. The founder can act as an external Chief Medical Officer or provide one-off advice. The firm’s expertise spans patient engagement, translational medicine, genetics, regulatory affairs, and business strategy within life sciences[1].

Therapeutic areas: Rare DiseasesOncology
Industry: Consulting

Beyond the preview

Go deeper on MEDExpansion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEDExpansion.

Explore the full profile